Funding for this research was provided by:
National Heart, Lung, and Blood Institute (5R01HL144706-02)
Received: 11 January 2021
Accepted: 10 May 2021
First Online: 19 June 2021
: All methods were carried out following relevant guidelines and regulations. The Yale Medical School IRB approved the study and waived the informed consent, as an exempt chart review study.
: Not applicable.
: EH is the founder of Medviso AB, Lund, Sweden, which sells a commercial version of the software Segment. The other authors declare that they have no competing interests.